About Us

Our mission is to improve the quality of life for millions of patients with visual disorders.

Over ten years of research and development at Bascome Palmer Eye Institute; ranked #1 in the US for ophthalmology.

Our Company Story

Heru is a spinoff company from the University of Miami’s Bascom Palmer Eye Institute.

Bascom Palmer is ranked the number one eye hospital in the U.S., and where our AI-driven diagnostics and vision augmentation platform is continuously developed.

Our technology is the culmination of over ten years of clinical and scientific research and development. This effort is led by Heru’s Founder and CEO Mohamed Abou Shousha, MD, PhD, associate professor of clinical ophthalmology, Bascom Palmer Eye Institute.

After years of feeling limited by options to help improve his patients’ lives, Dr. Abou Shousha became inspired and he and his team of leading physicians, scientists and engineers set out to develop Heru’s artificial intelligence (AI) powered wearable device.

Our mission is to improve the quality of life for the millions of patients living with visual defects and disorders.

Innovation

We are driven by innovation and our goal to provide physicians and patients with cutting-edge technology to help improve access to eye care.

The rapid introduction of telemedicine, and the rising prevalence of glaucoma worldwide, illustrates the need for a portable and user-friendly platform that offers a novel and more cost-effective means of testing.
Executive team

Heru’s Executive Team is comprised of esteemed physicians and executives with a wealth of experience in eye care, medical technology, and other industries.

Chief Executive Officer
Chief Marketing Officer
Chief Customer Officer
Chief Scientific Officer
Chief Technology Officer
VP of Strategy & Corporate Development
medical Advisory Board

Heru’s distinguished group of medical and scientific advisors hail from prestigious medical institutions, and are surgeons, academic leaders, researchers and authors.

Eduardo C. Alfonso, M.D​

Donald Budenz, MD, MPH

Pradeep Ramulu, MD, MHS, PhD

William H. Seiple, PhD

Board of Directors

Heru’s Board of Directors is comprised of esteemed physicians and executives with a wealth of experience in eye care, medical technology, and other industries.

Mohamed Abou Shousha, MD, FRCS, PhD

Founder, President, and Chief Executive Officer 

Mohamed Abou Shousha, MD, PhD is Heru’s President and Chief Executive Officer. Dr. Abou Shousha is a practicing Opthamologist at the University of Bascom Palmer Eye Institute, where he serves as Associate Professor of Clinical Opthamology, Electrical and Computer Engineering, and Biomedical Engineering.

 

Maurice R. Ferré, MD

Chairman of the Board

Maurice R. Ferré, MD is a seasoned serial entrepreneur in the medical technology industry. Dr. Ferré is currently Chief Executive Officer and Chairman of the Board at INSIGHTEC, the innovator of incisionless surgery. Prior to this, Dr. Ferré served as Chief Executive Officer and Chairman of the Board of MAKO Surgical Corporation, a robotic surgical company that he co-founded.

Richard K. Parrish II, MD

Board Member

Richard K. Parrish II, MD is a world-renown glaucoma specialist and is the Edward W.D. Norton Chair in Ophthalmology and Associate Dean for Graduate Medical Education ot the University of Miami Miller School of Medicine.  he also serves as Chairman of the Graduate Medical Education Committee and is the designated institutional representative for the Jackson Health System/Jackson Memorial Hospital.

Fred Drasner

Board Member

Fred Drasner is presently Chairman of the Three Seasons Capital, LLC, a venture capital firm. Mr. Drasner joined Shaw, Pittman, Potts, and Trowbridge (now Pillsbury Winthrop Shaw Pittman) in 1972 as a tax lawyer and served as its principal Tax Partner until 1985. In 1985, Mr. Drasner, with a partner, acquired U.S. News & World Report and served as its CEO and Co-Chairman from 1985 to 2004.

 

Rajesh Rajpal, MD

Board Member

Rajesh Rajpal, MD is the Founder of See Clearly Vision, a group practice in the Washington, D.C. Area. He previously served as Chief Medical Officer for Avedro (acquired by Glaukos) and is Chief Medical Officer and Global Head of Clinical and Medical Affairs at Johnson & Johnson Vision.

Kerri-Lynn Primmer Morris

Board Member

Kerri-Lynn is currently the Chief Technology Officer for Healthcare and Life Sciences for Microsoft Industry Solutions.  She serves as an advisor in the Mixed Reality and connected IoT space and is passionate about AR/VR/MR and IoT’s potential to healthcare.  Kerri-Lynn also previously held an executive role at Kaiser Permanente focused on driving the success of transformational programs.

Key Investors

Heru’s investors are a distinguished group of physicians and professionals in medical technology, real estate development, publishing and other key industries.

D1 capital

D1 Capital Partners is a global investment firm that operates across public and private markets. The firm combines the talent and operational excellence of a large, premier asset management firm with the flexible mandate and long-term time horizon of a family office. Founded in 2018 by Daniel Sundheim, D1 focuses on investing in the global internet, technology, telecom, media, consumer, healthcare, financial, industrial, and real estate sectors.

Softbank

SoftBank Group

SoftBank’s SB Opportunity Fund is a $100 million venture fund. SoftBank Group Corp. is a Japanese multinational conglomerate holding company headquartered in Minato, Tokyo. The Group primarily invests in companies operating in the technology, energy, and financial sectors.

Fred Drasner

Chairman of Three Seasons Capital, LLC

Fred Drasner is presently Chairman of Three Seasons Capital, LLC, a venture capital firm. Mr. Drasner joined Shaw, Pittman, Potts and Trowbridge (now Pillsbury Winthrop Shaw Pittman) in 1972 as a tax lawyer and served as its principal Tax Partner until 1985. In 1985, Mr. Drasner, with a partner, acquired U. S. News &World Report and served as its CEO and Co-Chairman from 1985 to 2004.

Maurice R. Ferré, MD

Chief Executive Officer and Chairman, INSIGHTEC

Maurice Ferré, MD is a seasoned serial entrepreneur in the medical technology industry. Dr. Ferré is currently Chief Executive Officer and Chairman of the Board at INSIGHTEC, the innovator of incisionless surgery. Prior to this, Dr. Ferré, served as Chief Executive Officer and Chairman of the Board of MAKO Surgical Corporation, a robotic surgical company that he co-founded.

Christopher C. Dewey

Partner, Ceros Financial Services

Christopher C. Dewey currently serves as a Managing Director of Ceros Financial Services, Inc. He was a Founder and President of The Cannon Group Inc, a/k/a Cannon Films, the first independent film company to finance, produce and distribute motion pictures worldwide. Cannon became a public company in 1972 and was thereafter sold.

Frederic H. Moll, MD

Chief Development Officer, Johnson and Johnson Medical Devices Companies

Frederic H. Moll, MD is a medical device developer and entrepreneur and has been called the father of robotic surgery. Dr. Moll is currently Chief Development Officer of Johnson & Johnson Medical Device Companies and serves on the board of directors of 11 other companies. Prior to this, he was CEO of Auris Health, Inc.

Robert Wennett

President, UIA Management

Robert Wennett is President of UIA Management, LLC (UIA) and has over 25 years of experience in acquisitions and structuring and negotiating real estate transactions aggregating three billion dollars in value. In his role as President, Mr. Wennett is responsible for UIA’s ambitious national development plan, as well as the creation and implementation of its investment and acquisition strategies.

Alberto Beeck

Managing Partner, VH Properties and Director, Virgin Hotels

Alberto Beeck is an investor who combines his time between different businesses and social impact activities in the education sector. He is Managing Partner of Cranley Investments Holdings, Managing Partner of VH Properties, and Chairman of Lumni (a company that invests in human capital).

Krillion Ventures

Jeffrey Miller, managing partner
Melissa Krinzman, managing partner

Krillion invests in entrepreneurs as well as in Miami. It is committed to maximizing the return on investment for the fund and is dedicated to strengthening South Florida to help to make it an even better place to live, work, and learn. 
Be the first to know

Receive product updates and get early access to Heru technologies.

This field is for validation purposes and should be left unchanged.